Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $124 Billion
  • Q1 2025

Bml Capital Management, LLC has filed its 13F form on May 06, 2025 for Q1 2025 where it was disclosed a total value porftolio of $124 Billion distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Atea Pharmaceuticals, Inc. with a value of $22.8B, Aclaris Therapeutics, Inc. with a value of $21.8B, Third Harmonic Bio, Inc. with a value of $13.3B, Adverum Biotechnologies Inc with a value of $12B, and An2 Therapeutics, Inc. with a value of $7.82B.

Examining the 13F form we can see an decrease of $37.4B in the current position value, from $161B to 124B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $124 Billion
Healthcare: $99.3 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $124 Billion
  • Prior Value $161 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 06, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 6 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email